MCHC

What is MCHC?

MCHC (Mean Corpuscular Haemoglobin Concentration) is the average haemoglobin concentration inside red blood cells, expressed in g/dL or g/L. The reference range for adults is typically 320–360 g/L (or 32–36 g/dL). Unlike MCH (which measures absolute weight per cell), MCHC corrects for cell size: it indicates how densely haemoglobin is packed within the cell volume. MCHC is calculated as haemoglobin (g/dL) divided by haematocrit, multiplied by 100. A low MCHC (hypochromia, < 320 g/L) fits iron-deficiency anaemia and thalassaemia: cells are insufficiently filled with haemoglobin, appearing pale red on microscopy. In iron deficiency, a low MCHC typically accompanies low MCV, low MCH, low ferritin, and low transferrin saturation. A raised MCHC (> 360 g/L) is rarer and clinically significant: the classic picture is hereditary spherocytosis, where the spherical cell has less volume per unit of haemoglobin, artificially raising the concentration. High MCHC can also be a laboratory artefact from cold agglutinins (which disrupt the red cell count), lipaemia, or severe hyperglycaemia — the laboratory typically checks for these when MCHC comes back unexpectedly high. MCHC is one of the more stable indices in the red cell picture and changes more slowly than RDW or reticulocytes with shifting iron status. It is therefore more a 'steady-state' marker of cell quality than an early-change marker.

Why is MCHC relevant?

MCHC is relevant as a refinement of the anaemia pattern, particularly for distinguishing iron deficiency from thalassaemia trait and from specific morphological abnormalities such as spherocytosis. In the most common anaemia — iron deficiency — MCH and MCV are more sensitive markers than MCHC, but a low MCHC confirms the pattern and strengthens the diagnosis when the other indices align. Elevated MCHC is the most clinically specific finding: when it is high alongside a fitting clinical picture — familial anaemia, mild jaundice, positive direct antiglobulin test (Coombs) — hereditary spherocytosis is the consideration. The distinction from autoimmune haemolytic anaemia is made clinically and through further blood work. A persistently high MCHC without laboratory artefact always warrants a repeat measurement and discussion with a clinician. For routine preventive monitoring, MCHC is more often a confirming marker than an initiating one: it strengthens or weakens patterns already flagged by MCV, MCH, and RDW. In the context of a full blood count with fitting symptoms, an abnormal MCHC always adds value to the interpretation.

MCHC high or low — what it means

MCHC is almost always read in the pattern of MCV, MCH, RDW, and haemoglobin, and when anaemia is suspected supplemented with ferritin, transferrin saturation, reticulocytes, and — for macrocytic patterns — B12, folate, and thyroid function. An isolated mildly low MCHC with an otherwise normal blood count and no symptoms calls for a repeat measurement, not immediate action. With an unexpectedly high MCHC (> 36 g/dL or > 360 g/L), the laboratory's first step is to exclude interferences: cold agglutinins cluster red cells at room temperature and can mislead the counter; lipaemia interferes with the photometric haemoglobin measurement; acute hyperglycaemia can affect cell swelling and thereby the haematocrit. If the high MCHC persists on a second sample — incubated at 37°C — a morphological review of the peripheral blood smear is the next step. For most healthy people in preventive blood testing, MCHC is a background marker that rarely warrants action on its own — its meaning lies in the overall red cell pattern and clinical context.

Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.